Jaguar Health (JAGX) Change in Account Payables (2014 - 2026)
Jaguar Health (JAGX) reported Change in Account Payables of -$3.8 million for Q1 2026, down 317.93% year-over-year from $1.7 million in Q1 2025, and down 1608.03% quarter-over-quarter from $249000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Account Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Account Payables data on file, last reported at -$3.8 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$3.8 million, down 317.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 157.45% YoY), and the FY2025 annual result was $3.3 million, up 920.12% from the prior year.
- Change in Account Payables slipped to -$3.8 million in Q1 2026 per JAGX's latest filing, from $249000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.9 million in Q2 2022 and troughed at -$3.8 million in Q1 2026.
- A 5-year average of -$2000.0 and a median of $249000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 643.24% in 2022, then slumped 1138.81% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$489000.0 in 2022, then jumped by 62.17% to -$185000.0 in 2023, then surged by 505.95% to $751000.0 in 2024, then sank by 66.84% to $249000.0 in 2025, then sank by 1608.03% to -$3.8 million in 2026.
- Business Quant data shows JAGX's Change in Account Payables at -$3.8 million in Q1 2026, $249000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -9.42 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | -3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.76 Mn |
| Mar 31, 2026 | -3.76 Mn |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | -438,000.00 |
| Jun 30, 2025 | -438,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 751,000.00 |
| Dec 31, 2024 | 751,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -185,000.00 |
| Dec 31, 2023 | -185,000.00 |